Literature DB >> 12802208

Functional characterisation of nucleoside transport in rat brain endothelial cells.

Mansoor Chishty1, David J Begley, N Joan Abbott, Andreas Reichel.   

Abstract

Multiple nucleoside transport systems exist in the body yet the subtypes functional at the blood-brain barrier (BBB) have not been fully investigated. We have employed RBE4 immortalised rat brain endothelial cells to functionally identify the carrier subtypes involved in nucleoside transfer between blood and brain. Uptake in RBE4 cells was partially sodium dependent, indicating the presence of both equilibrative and concentrative systems. Uptake of adenosine via equilibrative transporters was sensitive to nitro-benzylmercaptopurine riboside, which showed biphasic inhibition. Uptake of [3H]-adenosine via concentrative transporters was studied using the subtype-specific inhibitors thymidine (cit), formycin-B (cif) and tubercidin (cib) and was significantly reduced by thymidine and formycin-B but not by tubercidin. This study suggests that nucleoside transport at the in situ BBB may be mediated by ei and es equilibrative transporters and by cit and cif concentrative transporters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12802208     DOI: 10.1097/01.wnr.0000072843.93264.ff

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  7 in total

1.  Molecular and functional characterization of riboflavin specific transport system in rat brain capillary endothelial cells.

Authors:  Mitesh Patel; Ramya Krishna Vadlapatla; Dhananjay Pal; Ashim K Mitra
Journal:  Brain Res       Date:  2012-06-07       Impact factor: 3.252

2.  PET radiopharmaceuticals for probing enzymes in the brain.

Authors:  Jason P Holland; Paul Cumming; Neil Vasdev
Journal:  Am J Nucl Med Mol Imaging       Date:  2013-04-09

Review 3.  In vitro blood-brain barrier models: current and perspective technologies.

Authors:  Pooja Naik; Luca Cucullo
Journal:  J Pharm Sci       Date:  2011-12-27       Impact factor: 3.534

4.  Dynamic small-animal PET imaging of tumor proliferation with 3'-deoxy-3'-18F-fluorothymidine in a genetically engineered mouse model of high-grade gliomas.

Authors:  Michelle S Bradbury; Dolores Hambardzumyan; Pat B Zanzonico; Jazmin Schwartz; Shangde Cai; Eva M Burnazi; Valerie Longo; Steven M Larson; Eric C Holland
Journal:  J Nucl Med       Date:  2008-02-20       Impact factor: 10.057

5.  Nucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cells.

Authors:  Richard G E Archer; Václav Pitelka; James R Hammond
Journal:  Br J Pharmacol       Date:  2004-08-02       Impact factor: 8.739

6.  NCI-sponsored trial for the evaluation of safety and preliminary efficacy of 3'-deoxy-3'-[18F]fluorothymidine (FLT) as a marker of proliferation in patients with recurrent gliomas: preliminary efficacy studies.

Authors:  Alexander M Spence; Mark Muzi; Jeanne M Link; Finbarr O'Sullivan; Janet F Eary; John M Hoffman; Lalitha K Shankar; Kenneth A Krohn
Journal:  Mol Imaging Biol       Date:  2009-03-27       Impact factor: 3.488

7.  Uneven distribution of nucleoside transporters and intracellular enzymatic degradation prevent transport of intact [14C] adenosine across the sheep choroid plexus epithelium as a monolayer in primary culture.

Authors:  Zoran B Redzic; Aleksandra J Isakovic; Sonja T Misirlic Dencic; Dusan Popadic; Malcolm B Segal
Journal:  Cerebrospinal Fluid Res       Date:  2006-03-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.